| Name | ((1S,4aS,6S,7S,7aS)-6-acetoxy-7-(chloromethyl)-7-hydroxy-1-((3-methylbutanoyl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl)methyl 3-methylbutanoate | 
|---|---|
| Synonyms | Butanoic acid, 3-methyl-, [(1S,4aS,6S,7S,7aS)-6-(acetyloxy)-7-(chloromethyl)-1,4a,5,6,7,7a-hexahydro-7-hydroxy-1-(3-methyl-1-oxobutoxy)cyclopenta[c]pyran-4-yl]methyl ester {(1S,4aS,6S,7S,7aS)-6-Acetoxy-7-(chloromethyl)-7-hydroxy-1-[(3-methylbutanoyl)oxy]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl}methyl 3-methylbutanoate | 
| Description | Chlorovaltrate K is a chlorinated valepotriate with anticancer effects. Chlorovaltrate K shows moderate cytotoxicity against A549, PC-3M, HCT-8 and Bel 7402 cell lines with IC50 values of 2.32-8.26 μM[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.2±0.1 g/cm3 | 
|---|---|
| Boiling Point | 530.1±50.0 °C at 760 mmHg | 
| Molecular Formula | C22H33ClO8 | 
| Molecular Weight | 460.95 | 
| Flash Point | 274.4±30.1 °C | 
| Exact Mass | 460.186401 | 
| PSA | 108.36000 | 
| LogP | 2.28 | 
| Vapour Pressure | 0.0±3.2 mmHg at 25°C | 
| Index of Refraction | 1.518 | 
| Hazard Codes | Xi | 
|---|